Prenylated xanthones: Antiproliferative effects and enhancement of the growth inhibitory action of 4-hydroxytamoxifen in estrogen receptor-positive breast cancer cell line

Medicinal Chemistry Research

Volumn 21, Issue 5, 2012, Pages 552-558

  Paiva, Ana Mafalda ^a   Sousa, Maria Emília ^a   Camões, Ana ^a   Nascimento, Maria São José ^a   Pinto, Madalena Maria Magalhães ^a  

^a UNIVERSITY OF PORTO   (Portugal)

Author keywords

Antiestrogens; Antitumor; Prenylation; Xanthones

Indexed keywords

3,4 DYHYDROXYXANTH 9 ONE; AFIMOXIFENE; DIHYDRO 12 HYDROXY 2,2 DIMETHYL 2H,6H PYRANO[3,2 B]XANTHEN 6 ONE; DOXORUBICIN; ESTROGEN RECEPTOR; UNCLASSIFIED DRUG; XANTHONE DERIVATIVE;

ANTIPROLIFERATIVE ACTIVITY; ARTICLE; BREAST CANCER; CANCER CELL; CANCER INHIBITION; CONTROLLED STUDY; DRUG MECHANISM; DRUG POTENCY; DRUG STRUCTURE; DRUG SYNTHESIS; HUMAN; HUMAN CELL; IN VITRO STUDY;

EID: 84861841935     PISSN: 10542523     EISSN: 15548120     Source Type: Journal    
DOI: 10.1007/s00044-011-9562-z     Document Type: Article

References (29)

1. Botta B, Vitali A, Menendez P, Misiti D, Delle Monache G (2005) Prenylated flavonoids: pharmacology and biotechnology. Curr Med Chem 12:717-739
2. Castanheiro RAP, Pinto MMM, Silva AMS, Cravo SMM, Gales L, Damas AM, Nazareth N, Nascimento MSJ, Eaton G (2007) Dihydroxyxanthones prenylated derivatives: Synthesis, structure elucidation, and growth inhibitory activity on human tumor cell lines with improvement of selectivity for MCF-7. Bioorg Med Chem 15:6080-6088 (Pubitemid 47088964)
3. Coezy E, Borgna JL, Rochefort H (1982) Tamoxifen and metabolites in MCF7 cells: correlation between binding to estrogen receptor and inhibition of cell growth. Cancer Res 42:317-323 (Pubitemid 12207285)
4. Collins-Burow BM, Burow ME, Duong BN, McLachlan JA (2000) Estrogenic and antiestrogenic activities of flavonoid phytochemicals through estrogen receptor binding-dependent and -independent mechanisms. Nutr Cancer 38:229-244 (Pubitemid 32762024)
5. De Cos P, Bruyne T, Apers S, Vanden Berghe D, Pieters L, Vlietinck AJ (2003) Phytoestrogens: recent developments. Planta Med 69:589-599 (Pubitemid 37041052)
6. Gritzapis AD, Baxevanis CN, Missitzis I, Katsanou ES, Alexis MN, Yotis J, Papamichail M (2003) Quantitative fluorescence cytometric measurement of estrogen and progesterone receptors: correlation with the hormone binding assay. Breast Cancer Res Treat 80:1-13 (Pubitemid 36851280)
7. Guo Q-L, Lin S-S, You Q-D, Gu H-Y, Yu J, Zhao L, Qi Q, Liang F, Tan Z, Wang X (2006) Inhibition of human telomerase reverse transcriptase gene expression by Gambogic acid in human hepatoma SMMC-7721 cells. Life Sci 78:1238-1245 (Pubitemid 43179978)
8. Hamada M, Iikubo K, Ishikawa Y, Ikeda A, Umezawa K, Nishiyama S (2003) Biological activities of a-mangostin derivatives against acid sphingomyelinase. Bioorg Med Chem Lett 13:3151-3153 (Pubitemid 37093818)
9. Hopert AC, Beyer A, Frank K, Strunck E, Wunsche W, Vollmer G (1998) Characterization of estrogenicity of phytoestrogens in an endometrial-derived experimental model. Environ Health Perspect106:581-586 (Pubitemid 28495434)
10. Jensen J, Kitlen JW, Briand P, Labrie F, Lykkesfeldt AE (2003) Effect of antiestrogens and aromatase inhibitor on basal growth of the human breast cancer cell line MCF-7 in serum-free medium. J Steroid Biochem Mol Biol 84:469-478 (Pubitemid 36555769)
11. Journe F, Chaboteaux C, Dumon JC, Leclercq G, Laurent G, Body JJ (2004) Steroid-free medium discloses oestrogenic effects of the bisphosphonate clodronate on breast cancer cells. Br J Cancer 91:1703-1710 (Pubitemid 39546144)
12. Journe F, Chaboteaux C, Magne N, Duvillier H, Laurent G, Body JJ (2006) Additive growth inhibitory effects of ibandronate and antiestrogens in estrogen receptor-positive breast cancer cell lines. Breast Cancer Res 8:R2
13. Kitaoka M, Kadokawa H, Sugano M, Ichikawa K, Taki M, Takaishi S, Iijima Y, Tsutsumi S, Boriboon M, Akiyama T (1998) Prenylflavonoids: a new class of non-steroidal phytoestrogen (Part 1), Isolation of 8-isopentenylnaringenin and an initial study on its structure-activity relationship. Planta Med 64:511-515 (Pubitemid 28383882)
14. Matsumoto K, Akao Y, Yi H, Ohguchi K, Ito T, Tanaka T, Kobayashi E, Iinuma M, Nozawa Y (2004) Preferential target is mitochondria in a-mangostin-induced apoptosis in human leukemia HL60 cells. Bioorg Med Chem 12:5799-5806 (Pubitemid 39388179)
15. Milligan SR, Kalita JC, Heyerick A, Rong H, De Cooman L, De Keukeleire D (1999) Identification of a potent phytoestrogen in hops (Humulus lupulus L.) and beer. J Clin Endocrinol Metab 84:2249-2252 (Pubitemid 30647064)
16. Murata M, Midorikawa K, Koh M, Umezawa K, Kawanishi S (2004) Genistein and daidzein induce cell proliferation and their metabolites cause oxidative DNA damage in relation to isoflavoneinduced cancer of estrogen-sensitive organs. Biochemistry 43:2569-2577 (Pubitemid 38327852)
17. Palmeira A, Paiva A, Sousa E, Seca H, Almeida GM, Lima RT, Fernandes MX, Pinto M, Vasconcelos MH (2010) Insights into the in vitro antitumor mechanism of action of a new pyranoxanthone. Chem Biol Drug Des 76:43-58
18. Pedro MM, Cerqueira F, Sousa ME, Nascimento MSJ, Pinto MMM (2002) Xanthones as inhibitors of growth of human cancer cell lines and their effects on the proliferation of human lymphocytes in vitro. Bioorg Med Chem 10:3725-3730 (Pubitemid 36164676)
19. Pedro M, Lourenço CF, Cidade H, Kijjoa A, Pinto M, Nascimento MSJ (2006) Effects of natural prenylated flavones in the phenotypical ER (+) MCF-7 and ER (-) MDA-MB-231 human breast cancer cells. Toxicol Lett 164:24-36
20. Pinto MMM, Castanheiro R (2009) Natural prenylated xanthones: chemistry and biological activities. In: Goutam B (ed) Natural products chemistry. Biochemistry and Pharmacology, West Bengal, pp 520-675
21. Pinto MMM, Sousa ME, Nascimento MSJ (2005) Xanthone derivatives: new insights in biological activities. Curr Med Chem 12:2517-2538 (Pubitemid 41408417)
22. Rowlands JC, Berhow MA, Badger TM (2002) Estrogenic and antiproliferative properties of soy sapogenols in human breast cancer cells in vitro. Food Chem Toxicol 40:1767-1774 (Pubitemid 35284147)
23. Schmitt E, Dekant W, Stopper H (2001) Assaying the estrogenicity of phytoestrogens in cells of different estrogen sensitive tissues. Toxicol In Vitro 15:433-439 (Pubitemid 32889670)
24. Skehan P, Storeng R, Scudiero D, Monks A, McMahon J, Vistica D, Warren JT, Bokesch H, Kenney S, Boyd MR (1990) New colorimetric cytotoxicity assay for anticancer-drug screening. J Natl Cancer Inst 82:1107-1112 (Pubitemid 20213250)
25. Sousa EP, Silva AMS, Pinto MMM, Pedro MM, Cerqueira FAM, Nascimento MSJ (2002) Isomeric kielcorins and dihydroxyxanthones: synthesis, structure elucidation, and inhibitory activities of growth of human cancer cell lines and on the proliferation of human lymphocytes in vitro. Helv Chim Acta 85:2862-2876 (Pubitemid 35177805)
26. Sousa E, Paiva A, Nazareth N, Gales L, Damas AM, Nascimento MSJ, Pinto M (2009) Bromoalkoxyxanthones as promising antitumor agents: synthesis, crystal structure and effect on human tumor cell lines. Eur J Med Chem 44:3830-3835
27. Wakeling AE, Newboult E, Peters SW (1989) Effects of antioestrogens on the proliferation of MCF-7 human breast cancer cells. J Mol Endocrinol 2:225-234 (Pubitemid 19117459)
28. Wang C, Kurzer MS (1998) Effects of phytoestrogens on DNA synthesis in MCF-7 cells in the presence of estradiol or growth factors. Nutr Cancer 31:90-100 (Pubitemid 28428068)
29. Zhang HZ, Kasibhatla S, Wang Y, Herich J, Guastella J, Tseng B, Drewe J, Cai SX (2004) Discovery, characterization and SAR of gambogic acid as a potent apoptosis inducer by a HTS assay. Bioorg Med Chem 12:309-317 (Pubitemid 38064204)